Roxro’s NDA for pain drug accepted for review by FDA
ROX-888 is an intranasal formulation of ketorolac, a non-steroidal anti-inflammatory drug, designed to provide ambulatory patients with a convenient, potent, and fast-acting option for acute pain relief, without
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.